BibTex format
@article{Moore:2014:jac/dku307,
author = {Moore, LSP and Freeman, R and Gilchrist, MJ and Gharbi, M and Brannigan, ET and Donaldson, H and Livermore, DM and Holmes, AH},
doi = {jac/dku307},
journal = {Journal of Antimicrobial Chemotherapy},
pages = {3409--3422},
title = {Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108717 clinical isolates from primary, secondary and tertiary care patients in London.},
url = {http://dx.doi.org/10.1093/jac/dku307},
volume = {69},
year = {2014}
}
RIS format (EndNote, RefMan)
TY - JOUR
AB - Objectives We examined the 4 year trend in antimicrobial susceptibilities and prescribing across levels of care at two London teaching hospitals and their multisite renal unit, and for the surrounding community.Methods Laboratory and pharmacy information management systems were interrogated, with antimicrobial use and susceptibilities analysed between hospitals, within hospitals and over time.Results A total of 108717 isolates from 71687 patients were identified, with significant differences (at P<0.05) in antimicrobial susceptibility between and within hospitals. Across the 4 years, rates of ESBL-/AmpC-producing Enterobacteriaceae ranged from 6.4% to 10.7% among community isolates, 17.8% to 26.9% at ward level and 25.2% to 52.5% in critical care. Significant variations were also demonstrated in glycopeptide-resistant enterococci (ward level 6.2%–17.4%; critical care 21.9%–56.3%), MRSA (ward level 18.5%–38.2%; critical care 12.5%–47.9%) and carbapenem-resistant Pseudomonas spp. (ward level 8.3%–16.9%; critical care 19.9%–53.7%). Few instances of persistently higher resistance were seen between the hospitals in equivalent cohorts, despite persistently higher antimicrobial use in Hospital 1 than Hospital 2. We found significant fluctuations in non-susceptibility year on year across the cohorts, but with few persistent trends.Conclusions The marked heterogeneity of antimicrobial susceptibilities between hospitals, within hospitals and over time demands detailed, standardized surveillance and appropriate benchmarking to identify possible drivers and effective interventions. Homogeneous antimicrobial policies are unlikely to continue to be suitable as individual hospitals join hospital networks, and policies should be tailored to local resistance rates, at least at the hospital level, and possibly with finer resolution, particularly for critical care.
AU - Moore,LSP
AU - Freeman,R
AU - Gilchrist,MJ
AU - Gharbi,M
AU - Brannigan,ET
AU - Donaldson,H
AU - Livermore,DM
AU - Holmes,AH
DO - jac/dku307
EP - 3422
PY - 2014///
SN - 1460-2091
SP - 3409
TI - Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108717 clinical isolates from primary, secondary and tertiary care patients in London.
T2 - Journal of Antimicrobial Chemotherapy
UR - http://dx.doi.org/10.1093/jac/dku307
UR - http://hdl.handle.net/10044/1/41647
VL - 69
ER -
